Minerva Neurosciences | NERV - Lucro Operacional





Lucro Operacional Alterar Data
Acadia Pharmaceuticals USD 71.72M 33.88M 2026-09
Adma Biologics USD 52.44M 2.15M 2026-06
ALKERMES USD 36.59M 102.52M 2026-09
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
AstraZeneca USD 4.66B 1.5B 2026-09
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
Bristol-Myers Squibb USD 255M 44M 2026-09
Cipla INR 10.43B 1.55B 2026-09
Clal Biotechnology ILS -1.74M 7.46M 2022-12
Compugen USD -8.84M 180K 2026-06
CSL USD 2.64B 1.97B 2025-12
Eli Lilly USD 12.46B 2.68B 2026-06
GlaxoSmithKline GBP 2.86B 251M 2026-09
Grifols EUR 320.55M 91.01M 2025-12
Halozyme Therapeutics USD -63.72M 1.95M 2026-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
J&J USD 6.47B 1B 2026-09
Merck USD 7.33B 6.49B 2026-09
Minerva Neurosciences USD -21.85M 17.48M 2024-12
Neurocrine Biosciences USD 343M 123.1M 2026-09
Novartis USD 5.14B 392M 2026-09
Novavax USD 20.94M 100.32M 2025-12
Pfizer USD 662M 5M 2026-09
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 4.72B 2.34B 2026-09
Takeda JPY 205.32B 3.9B 2026-09
Vanda Pharmaceuticals USD -40.66M 29.66M 2024-12